Obesity Drug Spending Surges and Other U.S. Drug Trends for 2024
What Benefit Advisors Should Tell Their Clients About Discount Drug Programs
From Transparency to Gold Carding, 5 PBM State Regulation Trends from ’23
Newly Broadened 340B Patient Definition: How the Latest Genesis Court Decision Could Impact The Entire Industry
10 Specialty Drug Numbers You Need to Know for 2023
10 Fast Facts About the Pharmacy Benefits Industry
Protecting Your Clients Against Off-Label Ozempic
International Drug Sourcing: Examining the Risks and Potential Rewards
Enjoy our latest blogs, white papers and news by signing up for our newsletter today!